5303 篇
13870 篇
408834 篇
16090 篇
9269 篇
3870 篇
6469 篇
1239 篇
72413 篇
37118 篇
12061 篇
1621 篇
2824 篇
3387 篇
640 篇
1229 篇
1965 篇
4869 篇
3823 篇
5299 篇
全球疤痕治疗市场报告(2015-2019年)
Global Scar Treatment Market 2015-2019
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
03.1 Market Overview
03.2 Product Offerings
04. Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology
05. Introduction
06. Market Landscape
06.1 Market Overview
07. Global Scar Treatment Market
07.1 Market Overview
07.2 Market Size and Forecast
07.3 Five Forces Analysis
08. Market Segmentation by Application
08.1 Segmentation of Global Scar Treatment Market
by Application
08.1.1 Burn Scars
08.1.2 Post-surgical Scars Other than Burn Scars
08.1.3 Others
09. Market Segmentation by Type of Treatment
09.1 Segmentation of Global Scar Treatment Market
by Type of Treatment
09.2 OTC Scar Treatment Products
09.3 Alternative Treatment Methods
09.3.1 Dressings and Compression Treatment
09.3.2 Massage Treatment
09.3.3 Laser Treatment and Radiotherapy
09.3.4 Corticosteroid Treatment
09.3.5 Cryotherapy
09.3.6 Surgical Revision
10. Geographical Segmentation
10.1 Segmentation of Global Scar Treatment Market
by Geography 2014-2019
10.2 Scar Treatment Market in Europe
10.2.1 Market Size and Forecast
10.3 Scar Treatment Market in US
10.3.1 Market Size and Forecast
10.4 Scar Treatment Market in ROW
10.4.1 Market Size and Forecast
11. Buying Criteria
12. Market Growth Drivers
13. Drivers and their Impact
14. Market Challenges
15. Impact of Drivers and Challenges
16. Market Trends
17. Trends and their Impact
18. Vendor Landscape
18.1 Competitive Scenario
18.2 Major Vendors 2014
18.2.1 Key News
18.3 Other Prominent Vendors
18.4 Product Portfolio: Other Prominent Vendors
19. Key Vendor Analysis
19.1 Avita Medical
19.1.1 Key Facts
19.1.2 Business Overview
19.1.3 Business Segmentation by Revenue 2014
19.1.4 Business Segmentation by Revenue 2013 and 2014
19.1.5 Geographical Segmentation by Revenue 2014
19.1.6 Business Strategy
19.1.7 Recent Developments
19.1.8 SWOT Analysis
19.2 CCA Industries
19.2.1 Key Facts
19.2.2 Business Overview
19.2.3 Product Segmentation by Revenue 2013
19.2.4 Product Segmentation by Revenue 2012 and 2013
19.2.5 Geographical Segmentation by Revenue 2013
19.2.6 Business Strategy
19.2.7 Recent Developments
19.2.8 SWOT Analysis
19.3 Enaltus
19.3.1 Key Facts
19.3.2 Business Overview
19.3.3 SWOT Analysis
19.4 Merz Pharma
19.4.1 Key Facts
19.4.2 Business Overview
19.4.3 Subsidiaries
19.4.4 Key Products
19.4.5 Therapeutic Areas
19.4.6 Geographical Presence
19.4.7 Business Strategy
19.4.8 Recent Developments
19.4.9 SWOT Analysis
19.5 Oculus Innovative Sciences
19.5.1 Key Facts
19.5.2 Business Overview
19.5.3 Segmentation by Revenue 2014
19.5.4 Segmentation by Revenue 2013 and 2014
19.5.5 Geographical Segmentation by Product Revenue 2014
19.5.6 Business Strategy
19.5.7 Recent Developments
19.5.8 SWOT Analysis
19.6 Pacific World
19.6.1 Key Facts
19.6.2 Business Overview
19.6.3 Recent Developments
19.6.4 SWOT Analysis
19.7 Revitol
19.7.1 Key Facts
19.7.2 Business Overview
19.7.3 Product Segmentation
19.7.4 SWOT Analysis
19.8 Scarguard Labs
19.8.1 Key Facts
19.8.2 Business Overview
19.8.3 Key Products
19.8.4 SWOT Analysis
19.9 Suneva Medical
19.9.1 Key Facts
19.9.2 Business Overview
19.9.3 Key Offerings
19.9.4 Business Strategy
19.9.5 Recent Developments
19.9.6 SWOT Analysis
19.10 Valeant Pharmaceuticals International
19.10.1 Key Facts
19.10.2 Business Overview
19.10.3 Business Segmentation by Revenue 2013
19.10.4 Business Segmentation by Revenue 2012 and 2013
19.10.5 Sales by Geography
19.10.6 Business Strategy
19.10.7 Key Developments
19.10.8 SWOT Analysis
20. Other Reports in this Series